PharmaCielo Ltd.
PCLOF
$0.07
$0.0250.93%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.83M | 1.27M | 1.64M | 1.97M | 2.31M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.83M | 1.27M | 1.64M | 1.97M | 2.31M |
| Cost of Revenue | 1.31M | 1.48M | 2.22M | 1.92M | 2.01M |
| Gross Profit | 516.00K | -211.10K | -586.20K | 47.00K | 291.70K |
| SG&A Expenses | 2.88M | 3.05M | 3.56M | 2.90M | 3.69M |
| Depreciation & Amortization | 58.40K | 100.00K | 112.10K | 111.70K | 134.20K |
| Other Operating Expenses | -107.30K | -796.60K | -268.90K | -262.00K | -149.40K |
| Total Operating Expenses | 4.15M | 3.83M | 5.62M | 4.67M | 5.69M |
| Operating Income | -2.32M | -2.56M | -3.98M | -2.70M | -3.38M |
| Income Before Tax | -2.59M | -3.31M | -4.67M | -5.61M | -6.55M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.59 | -3.31 | -4.67 | -5.61 | -6.55 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.59M | -3.31M | -4.67M | -5.61M | -6.55M |
| EBIT | -2.32M | -2.56M | -3.98M | -2.70M | -3.38M |
| EBITDA | -1.31M | -1.87M | -3.40M | -2.00M | -2.44M |
| EPS Basic | -0.01 | -0.02 | -0.03 | -0.03 | -0.04 |
| Normalized Basic EPS | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.01 | -0.02 | -0.03 | -0.03 | -0.04 |
| Normalized Diluted EPS | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 753.93M | 748.36M | 735.65M | 717.41M | 699.17M |
| Average Diluted Shares Outstanding | 753.93M | 748.36M | 735.65M | 717.41M | 699.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |